Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson’s disease: A prospective study using single-dose challenges - Katzenschlager, R; Hughes, A; Evans, A; Manson, AJ; Hoffmann, M; Swinn, L (Mov Disord, 2005)
et al.